Alyeska Investment Group
HLF icon

Alyeska Investment Group’s Herbalife HLF Stock Holding History

Alyeska Investment Group’s Portfolio HLF Stock Details HLF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,000,000
Closed -$33.9M – 475
2017
Q3 		$33.9M Buy
+1,000,000
New +$34.2M 0.25% 130

Other funds holding HLF

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
DVI
Deccan Value Investors Greenwich, Connecticut $84.6M AUM 57.32% 1-Year Est. Return
ROIC
Route One Investment Company San Francisco, California $2.35B AUM 11.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Alyeska Investment Group's HLF Position: Q4 2017 in Review

Alyeska Investment Group sold out of Herbalife (HLF) in Q4 2017, closing a stake of 1,020,418 shares — an estimated $34.6M sold.

Alyeska Investment Group first reported a position in HLF in Q3 2017 and held it in 1 quarter. The position peaked at $34.6M in Q3 2017. 203 funds tracked by Wall St. Rank hold HLF as of Q4 2017.

  • Alyeska Investment Group reported no remaining Herbalife position as of Q4 2017 after selling out during the quarter.
  • Alyeska Investment Group sold 1,020,418 Herbalife shares in Q4 2017, an estimated $34.6M.
  • Alyeska Investment Group first reported a position in Herbalife in Q3 2017 and held it in 1 quarter.
  • Alyeska Investment Group's Herbalife position peaked at $34.6M in Q3 2017.
  • 203 funds tracked by Wall St. Rank held Herbalife as of Q4 2017.

Based on Alyeska Investment Group's 13F filing for Q4 2017, filed 14 Feb 2018.